Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11981715 Tissue targeted immunotolerance with a CD39 effector

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 15 May, 2024
"Created via: Patent importer"
Golden AI profile picture
Golden AI
created this topic on 15 May, 2024
Edits made to:
Infobox (+101 properties)
Article (+113 characters)
‌

 US Patent 11981715 Tissue targeted immunotolerance with a CD39 effector

Article

Patent abstract

Methods and compounds for conferring site-specific or local immune privilege, such as to the skin.

Infobox
Is a
Patent
Patent
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
119817150
Patent Inventor Names
Daniel Rios0
Joanne L. Viney0
Kevin Lewis Otipoby0
Lindsay J. Edwards0
Nathan Higginson-Scott0
Purvi Mande0
Salvatore Alioto0
Susmita Borthakur0
Date of Patent
May 14, 2024
0
Patent Application Number
171789260
Date Filed
February 18, 2021
0
Patent Citations
‌
US Patent 7105653 IL-2 selective agonists and antagonists
0
‌
US Patent 7138103 Use of bi-specific antibodies for pre-targeting diagnosis and therapy
0
‌
US Patent 7186804 IL-2 fusion proteins with modulated selectivity
0
‌
US Patent 7306801 Methods of therapy for cancers characterized by overexpression of the HER2 receptor protein
0
‌
US Patent 7371371 Interleukin-2 mutants with reduced toxicity
0
‌
US Patent 7462350 Cancer treatments including administering IL-2 fusion proteins with modulated selectivity
0
‌
US Patent 7514073 Therapeutic use of interleukin-2 mutants
0
‌
US Patent 7569215 Mutant interleukin-2 (IL-2) polypeptides
0
‌
US Patent 7803361 Therapeutic use of interleukin-2 mutants
0
‌
US Patent 7807142 Stabilized liquid polypeptide-containing pharmaceutical compositions
0
‌
US Patent 7888071 DNA encoding IL-2 fusion proteins with modulated selectivity
0
‌
US Patent 7951360 Mutant interleukin-2 (IL-2) polypeptides
0
‌
US Patent 8012465 Methods for treating renal cell carcinoma
0
‌
US Patent 8124066 Methods of using interleukin-2 mutants with reduced toxicity
0
‌
US Patent 8349311 Mutant interleukin-2 (IL-2) polypeptides
0
‌
US Patent 8354110 Compositions and methods for the prevention and treatment of autoimmune conditions
0
‌
US Patent 8454963 Tissue targeted complement modulators
0
‌
US Patent 8759486 Immunomodulatory interleukin-2 polypeptides and methods of treating melanoma
0
‌
US Patent 8815235 Tissue-specific imaging and therapeutic agents targeting proteins expressed on lung endothelial cell surface
0
‌
US Patent 8815297 Modulation of beta 2 adrenergic receptors by inhibitors of EGLN3 or pVHL
0
‌
US Patent 8906356 Mutant interleukin-2 (IL-2) polypeptides
0
‌
US Patent 8993731 PD-1 antibody
0
‌
US Patent 9206243 IL-2 derivative polypeptides
0
‌
US Patent 9266938 Mutant interleukin-2 polypeptides
0
‌
US Patent 9308280 Targeting of antigen presenting cells with immunonanotherapeutics
0
‌
US Patent 9388231 Multivalent heteromultimer scaffold design and constructs
0
‌
US Patent 9428567 Antagonists of interleukin-2 receptor
0
‌
US Patent 9447159 Immunoconjugates
0
‌
US Patent 9493564 CD86 antagonist multi-target binding proteins
0
‌
US Patent 9499603 PD-1 antibodies
0
‌
US Patent 9499605 Multivalent heteromultimer scaffold design and constructs
0
‌
US Patent 9499634 Process and methods for efficient manufacturing of highly pure asymmetric antibodies in mammalian cells
0
‌
US Patent 9526797 Combination IL-2 immunoconjugate therapy
0
‌
US Patent 9562109 Stable heterodimeric antibody design with mutations in the Fc domain
0
‌
US Patent 9574010 Stable heterodimeric antibody design with mutations in the Fc domain
0
‌
US Patent 9580486 Interleukin-2 muteins for the expansion of T-regulatory cells
0
‌
US Patent 9616105 Agent for the treatment and/or prophylaxis of an autoimmune disease and for the formation of regulatory T cells
0
‌
US Patent 9732134 Method of treating graft versus host disease using IL-2 muteins
0
‌
US Patent 9844582 Synergistic tumor treatment with extended-PK IL-2 and therapeutic agents
0
‌
US Patent 9932380 Interleukin-2 muteins for the expansion of T-regulatory cells
0
‌
US Patent 10035836 Modified IL-2 variants that selectively activate regulatory T cells
0
‌
US Patent 10086046 Agent for the treatment and or prophylaxis of an autoimmune disease and for the formation of regulatory T cells
0
‌
US Patent 10093711 Interleukin-2 muteins for the expansion of T-regulatory cells
0
‌
US Patent 10130659 Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
0
‌
US Patent 10137206 Nucleic acid products and methods of administration thereof
0
‌
US Patent 10138298 Anti-IL-2 antibodies and compositions and uses thereof
0
‌
US Patent 10150802 Superagonists, partial agonists and antagonists of interleukin-2
0
‌
US Patent 10166257 Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
0
‌
US Patent 10166273 Synergistic tumor treatment with antibodies targeting PD-1, PD-L1 or CTLA4 and integrin-binding-Fc-fusion protein
0
‌
US Patent 10174091 IL-2 muteins
0
‌
US Patent 10174092 IL-2 muteins
0
‌
US Patent 10183980 Superagonists and antagonists of interleukin-2
0
‌
US Patent 10184009 Mutant interleukin-2 polypeptides
0
‌
US Patent 10202464 Immunoconjugates
0
‌
US Patent 10227411 Modulation of T cells with bispecific antibodies and FC fusions
0
‌
US Patent 10227415 Methods of producing a zcytor17 heterodimeric cytokine receptor
0
‌
US Patent 10232053 Immunomodulatory oncolytic adenoviral vectors, and methods of production and use thereof for treatment of cancer
0
‌
US Patent 10251945 Anti-ICOS agonist antibodies and uses thereof
0
‌
US Patent 10260038 Protein modification of living cells using sortase
0
‌
US Patent 10272113 Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
0
‌
US Patent 10308696 IL2 and TNF immunoconjugates
0
‌
US Patent 10286113 Bone morphogenetic protein pathway activation, compositions for ossification, and methods related thereto
0
‌
US Patent 10316104 Immunoconjugates
0
‌
US Patent 10293028 Use of low dose IL-2 for treating autoimmune related or inflammatory disorders
0
‌
US Patent 10293058 RNA containing composition for treatment of tumor diseases
0
‌
US Patent 10294287 Molecules that selectively activate regulatory T cells for the treatment of autoimmune diseases
0
‌
US Patent 10294305 Method for treating a GD2 positive cancer
0
‌
US Patent 10273489 Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier
0
‌
US Patent 10301384 Antibodies to IL-15
0
‌
US Patent 10323077 Expression of chimeric polypeptide with variable lymphocyte receptors on immune cells and uses for treating cancer
0
‌
US Patent 10323098 Mutant interleukin-2 polypeptides
0
‌
US Patent 10336801 Chemokine-cytokine fusion proteins of SDF-1 and CD40L
0
‌
US Patent 10350266 Method of treating cancer with a multiple integrin binding Fc fusion protein
0
‌
US Patent 10350304 Nucleic acid products and methods of administration thereof
0
‌
US Patent 10358477 IL-15Ralpha sushi domain—IL-15 fusion proteins
0
‌
US Patent 10363273 Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
0
‌
US Patent 10363321 Nucleic acid products and methods of administration thereof
0
‌
US Patent 10376564 Interleukin-2 for treating food allergy
0
‌
US Patent 10428145 PD-1 binding proteins and methods of use thereof
0
‌
US Patent 10493148 PD-1 agonist antibodies and uses thereof
0
‌
US Patent 10676516 Targeted immunotolerance
0
‌
US Patent 10751414 Methods of treating psoriasis using PD-1 binding antibodies
0
‌
US Patent 10766958 Methods of treating vitiligo using PD-1 binding antibodies
0
‌
US Patent 6927043 Interleukin-2 mutein expressed from mammalian cells
0
‌
US Patent 6955807 IL-2 selective agonists and antagonists
0
‌
US Patent 7048924 Combination antiviral and interleukin-2 therapy for HIV infection
0
Patent Primary Examiner
‌
Ruixiang Li
0

Find more entities like US Patent 11981715 Tissue targeted immunotolerance with a CD39 effector

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo